
Recursive self-improvement (RSI) is gaining traction in AI circles, much like AGI did before. The idea is for AI systems to autonomously enhance themselves, potentially leading to rapid advancements. Researchers like Richard Socher and Andrej Karpathy are exploring this with projects like Auto-Research, which uses agent swarms to train models. While full RSI remains elusive, the concept is attracting significant attention and investment, suggesting a future where AI could independently drive its own progress.
Read original
© TechCrunch AIGlean has achieved a remarkable $300 million in annual recurring revenue, tripling its figures in just 15 months. This growth is particularly notable as the company faces new competition from tech giants like Google and Microsoft in the enterprise AI search market. Glean's edge lies in its 'context graph' technology, which enhances AI efficiency by reducing computing costs for enterprises. This feature is increasingly appealing to businesses aiming to manage their AI budgets more effectively. As the market becomes more crowded, Glean's ability to offer tailored AI solutions gives it a significant advantage. The company's revenue model, which includes both consumption-based and hybrid pricing, reflects its adaptability to client needs.
© TechCrunch AIAWS is reshaping its cloud infrastructure to better accommodate AI agents with the launch of its next-generation OpenSearch Serverless. This new system is designed to handle the unpredictable traffic patterns of AI agents, scaling compute resources up and down as needed, which can significantly reduce costs for users. By decoupling compute from storage, AWS allows for instant scalability, ensuring that resources are only used when necessary. This shift reflects a broader industry trend as cloud providers adapt to the growing presence of machine-generated traffic, making AI agents more efficient and cost-effective to deploy.
© TechCrunch AIAsana's acquisition of StackAI marks a strategic move to enhance its AI capabilities and position itself as a leader in AI-native workplace platforms. By integrating StackAI's no-code agent-building technology, Asana aims to deepen its integration into existing business systems like Salesforce and Slack, offering more sophisticated automation solutions. This acquisition is part of Asana's broader AI pivot, which includes products like AI Studio and AI Teammates. Despite recent market challenges, Asana's leadership is optimistic that these advancements will drive growth and recovery.
© MIT News AIMIT is set to establish the Quantum Systems Laboratory (QSL) with support from the Commonwealth of Massachusetts, aiming to position the region as a leader in quantum innovation. The facility will provide state-of-the-art resources for quantum computing and research, integrating quantum sensors and peripherals. This initiative is expected to drive significant advancements in fields like life sciences and defense, while also creating job opportunities and fostering startup growth. By enhancing Massachusetts' quantum capabilities, the QSL aims to secure the state's role in the next era of technological breakthroughs.
© NVIDIA BlogNVIDIA's latest research is pushing the boundaries of robotics by enhancing the transition from simulation to real-world applications. At the ICRA conference, NVIDIA showcased eight papers that highlight advancements in robotic perception, reasoning, and action across unpredictable environments. These innovations include multi-arm coordination, adaptive grasping, and navigation across diverse robot bodies, all trained in simulation without real-world data. This approach not only speeds up robotic processes but also improves success rates significantly, marking a step forward in creating adaptable and reliable autonomous robots.
© The Rundown AIBiohub, backed by Mark Zuckerberg and Priscilla Chan, has unveiled a groundbreaking open-source model for protein biology. This 'world model' aims to accelerate drug discovery by predicting and designing proteins, potentially reducing the time from years to months. The model, ESMFold2, claims state-of-the-art performance in protein structure prediction, surpassing even AlphaFold. It has already shown promising results in designing binders for cancer and immune disease targets. This release could democratize access to advanced molecular tools, empowering researchers worldwide to tackle diseases more effectively.